Prospective cohort study of 93 Systemic sclerosis patients with ILD; 2/3 had diffuse SSc. Half had PH diagnosis w/in 7 yrs of SSc onset, 83% Rx with ILD therapy, 83% Rx for PH. Survival rate for SSc-ILD and PH at 3 years after PH diagnosis was 91%. https://t.co/ZmOmWutwxq